These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1773579)

  • 21. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
    Oberwittler H; Hirschfeld-Warneken A; Wesch R; Willerich H; Teichert L; Lehr KH; Ding R; Haefeli WE; Mikus G
    J Clin Pharmacol; 2007 Jan; 47(1):70-7. PubMed ID: 17192504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
    Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
    Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
    Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
    Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations.
    Godley PJ; Black JT; Frohna PA; Garrelts JC
    Ther Drug Monit; 1988; 10(3):287-91. PubMed ID: 3176104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation.
    Svec JM; Coleman RW; Mungall DR; Ludden TM
    Ther Drug Monit; 1985; 7(2):174-80. PubMed ID: 4024210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing.
    White RH; Hong R; Venook AP; Daschbach MM; Murray W; Mungall DR; Coleman RW
    J Gen Intern Med; 1987; 2(3):141-8. PubMed ID: 3295148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the daily prothrombin time response to warfarin.
    Farrow L; Mungall D; Raskob G; Hull R
    Ther Drug Monit; 1990 May; 12(3):246-9. PubMed ID: 2349607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens.
    Pitsiu M; Parker EM; Aarons L; Rowland M
    Ther Drug Monit; 2003 Feb; 25(1):36-40. PubMed ID: 12548142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model for planning optimal follow-up for outpatients on warfarin anticoagulation. Warfarin Optimal Outpatient Follow-up Study Group.
    Kent DL; Vermes D; McDonell M; Henikoff J; Fihn SD
    Med Decis Making; 1992; 12(2):132-41. PubMed ID: 1573980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective comparative study of computer programs used for management of warfarin.
    Poller L; Wright D; Rowlands M
    J Clin Pathol; 1993 Apr; 46(4):299-303. PubMed ID: 8496384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a Bayesian regression program for predicting warfarin response.
    Boyle DA; Ludden TM; Carter BL; Becker AJ; Taylor JW
    Ther Drug Monit; 1989; 11(3):276-84. PubMed ID: 2728086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements.
    Lubetsky A; Seligsohn U; Ezra D; Halkin H
    Clin Pharmacol Ther; 1992 Jul; 52(1):42-9. PubMed ID: 1385564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a bayesian forecasting method for warfarin dose individualization.
    Wright DF; Duffull SB
    Pharm Res; 2011 May; 28(5):1100-11. PubMed ID: 21301936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple technique for predicting maintenance dosage of warfarin--is it better than empirical dosing?
    Ovesen L; Lyduch S; Ott P
    Eur J Clin Pharmacol; 1989; 37(6):573-6. PubMed ID: 2612552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive performance of two software packages (USC*PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients.
    Gauthier T; Lacarelle B; Marre F; Villard PH; Catalin J; Durand A
    Int J Biomed Comput; 1994 Jun; 36(1-2):131-4. PubMed ID: 7927852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualised medicine: why we need Bayesian dosing.
    Donagher J; Martin JH; Barras MA
    Intern Med J; 2017 May; 47(5):593-600. PubMed ID: 28503880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics of warfarin at steady state.
    Murray B; Coleman R; McWaters D; Ludden T; Mungall D
    Ther Drug Monit; 1987; 9(1):1-5. PubMed ID: 3576653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose.
    Cosh DG; Moritz CK; Ashman KJ; Dally RJ; Gallus AS
    Aust N Z J Med; 1989 Jun; 19(3):191-7. PubMed ID: 2775039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.